. The first link between the terms 'pluripotency' and 'stem cell' in the sense that is commonly understood today was made by Martin Evans in 1972 (REF. 4) when he described the in vitro culturing of pluripotent cells from tera tomas. PSCs had been previously derived from teratomas (which are benign) and teratocarcinomas (which are malignant) by other researchers, but they did not use the term PSC [5] [6] [7] . The pioneering work involving these rare and bizarre tumours (which is reviewed in REF. 8 ) led to three main advancements: first, the development of conditions for culturing pluri potent embryonic carcinoma cells; second, the discovery of embryonal carcinoma cell-specific surface antigens; and third, the establishment of functional assays for testing the developmental potency of pluripotent cells. These advancements proved to be instrumental for isolating pluripotent cells from normal embryos.
Pluripotency is a transient property of cells within the early embryo. This property can be captured in vitro in the form of PSCs at different developmental time periods 9 . Pluripotent cells first arise in the inner cell mass (ICM) of the blastocyst-stage mouse embryo (cells in earlier stages, including the morula stage and two-cell and four-cell embryos, are considered totipotent). Pluripotent embryonic stem cells (ESCs) were first derived from the ICM of pre-implantation embryos that were explanted on feeder cells in the presence of serum 10, 11 . Pluripotency can also be captured at later time points during germline development by epi genetically reprogramming uni potent primordial germ cells in vitro 12 . PSCs obtained in this manner are called embryonic germ cells, and they are nearly indistinguishable from ESCs.
Pluripotency, either existing in vivo or captured in vitro, can be defined by several functional assays, including differentiation into the three germ layers in vitro, formation of teratomas in vivo, chimaera formation and germline transmission through blastocyst injection, and tetraploid complementation. The latter is considered the most stringent test for pluripotency. Mouse ESCs, similarly to the early epiblast from which they are derived, satisfy all of these criteria and are considered to be in a naive state of pluripotency 10, 11, 13 . By contrast, PSCs derived from post-implantation mouse epiblasts, which are termed epiblast stem cells (epiSCs), do not efficiently contribute to chimaera formation at the blastocyst stage but can readily participate in chimeric embryo formation when introduced into the post-implantation epiblast [14] [15] [16] [17] [18] . EpiSCs are thus thought to represent a more developmentally advanced pluripotent state: that is, a 'primed' state of pluripotency 14, 15 . Intriguingly, epiSCs and human ESCs have many commonalities, including dependence on activin A and fibroblast growth factor 2 (FGF2), a flat colony morphology and poor single-cell survival, which suggests that human ESCs are also in a primed state. Two recent studies 17, 18 have described the conditions that capture new types of primed pluripotency. PSCs derived under these conditions take on specific regional properties and show affinity for specific regions of the epiblast when re-introduced into the developing embryo.
Trophectoderm
The outer cell layer of a blastocyst. It is formed from the first specialized lineage of cells and gives rise to extra-embryonic tissues.
Mesendoderm
A layer of cells that are formed during early gastrulation, and are destined to become mesoderm and endoderm.
Ectoderm
The outermost of the three germ layers that are formed during gastrulation of the early embryo. Ectoderm-derived tissues include the nervous system, sensory organs and the skin.
Stemness genes
Genes that constitute the stem cell-specific gene expression programme.
Epithelial-mesenchymal transition (EMT). A process in which cells
of an epithelial layer lose their polarity and cell-cell adhesion, and become disorganized migratory mesenchymal cells. EMT is an integral part of normal developmental, wound healing and cancer development.
The pluripotency state is governed by a highly interconnected pluripotency gene regulatory network (PGRN) that is functionally anchored by a set of core pluripotency transcription factors. The fundamental importance of these transcription factors in the acquisition and maintenance of pluripotency is best illustrated by the reprogramming of induced PSCs (iPSCs), whereby certain combinations of pluripotency factors are sufficient to override the epigenetic mechanisms that safeguard the somatic cell fate and to reinstate the pluripotency state de novo 19, 20 . In this Review, we discuss the mechanisms by which the PGRN governs the acquisition, maintenance and dissolution of the pluripotency state. We consider interactions between the PGRN and additional layers of regulation that involve chromatin-mediated and RNA-mediated mechanisms. We also discuss the emerging wide range of alternative states of pluripotency and the transition between different states.
The core PGRN A few core pluripotency transcription factors serve as the hub of the PGRN and instigate a cascade of regulatory events that, together with many other transcription factors and cofactors, maintain the pluripotent state 21, 22 . Octamer-binding transcription factor 4 (OCT4; also known as POU5F1) is uniquely expressed in ESCs and primordial germ cells, and is essential for both in vivo and in vitro pluripotency [23] [24] [25] . Similarly, SRY-box 2 (SOX2) is required for the formation of the pluripotent epiblast and is a key regulator of Oct4 expression in ESCs 26, 27 . The loss of OCT4 or SOX2 promotes trophectoderm differentiation, whereas the overexpression of OCT4 or SOX2 leads to the differentiation of mesendoderm or neural ectoderm, respectively 25, 28 . Thus, precise regulation of OCT4 and SOX2 serves as the foundation of the PGRN. NANOG is also considered a core pluripotency transcription factor because of its important role in the acquisition of pluripotency in the ICM and its ability to enable leukaemia inhibitory factor (LIF)-independent self-renewal when overexpressed in ESCs (although its absence is compatible with the m aintenance of ESCs) [29] [30] [31] [32] [33] . Numerous studies have used high-throughput systems biology tools to dissect the PGRN. These tools include the following: microarrays and RNA sequencing (RNA-seq) for profiling gene expression in wildtype or genetically modified ESCs; immunoprecipitation coupled with mass spectrometry proteomics for assessing the protein interactome; and high-throughput chromatin immunoprecipitation (ChIP)-based methods for mapping the genomic occupancy of core pluri potency transcription factors. The findings from studies using these tools have been extensively reviewed 21, 22, 34, 35 . Evidence to date can be distilled into our current understanding of the PGRN. OCT4, SOX2 and NANOG function together and co-occupy hundreds of potential regulatory elements in the genome, including their own promoters, thus forming densely interconnected feedback and feedforward regulatory loops. Colocalized core transcription factors provide a platform for recruiting additional factors that integrate regulatory inputs from signalling pathways, other transcriptional circuits, coactivators and co-repressors, regulatory RNAs, and epigenetic mechanisms 21, 36, 37 . In such a system, fluctuations in the concentration of core transcription factors are either buffered by regulatory redundancy and positive feedback (resulting in stabilization of the pluripotent state), or exploited to initiate differentiation in an appropriate signalling environment (FIG. 1) . This bistability results from protein-DNA and protein-protein interactions that characterize the PGRN 38 .
Co-occupancy of core pluripotency transcription factors. OCT4 and SOX2 cooperatively bind many genomic sites as heterodimers 39, 40 . NANOG binding also shows extensive overlap with that of OCT4 and SOX2 (REF. 41 ). Sites bound by these three core transcription factors often exhibit enhancer activity. Importantly, genes adjacent to these potential enhancers are enriched for the gene ontology terms 'self-renewal' and 'differentiation' , which again suggests that this core pluripotency circuit generates a bistable state within ESCs 21 . However, there may be functional differences between the OCT4 and SOX2 module and the NANOG module. OCT4 and SOX2 are uniformly expressed at tightly controlled levels across the entire population of ESCs, and are highly expressed in both the naive and primed pluripotency states. By contrast, NANOG may be expressed at high or low levels in an ostensibly uniform population of ESCs, and it is downregulated in the primed pluripotency state 31, 42 . Cells that completely lack NANOG can still self-renew in an undifferentiated state, albeit with a propensity for differentiation that is much higher than that of wild-type cells 31 . Many putative target genes (including pluripotency-associated genes) bound by NANOG remain expressed in the absence of NANOG 43 . Thus, the role of NANOG seems to be safeguarding naive pluripotency against pro-differentiation signals rather than activating self-renewal genes per se.
Recent evidence provides new insights into the molecular basis underlying OCT4 and SOX2 complex formation and their co-binding to DNA targets. Single-molecule imaging has revealed how OCT4 and SOX2 assemble on their cognate DNA sites 44 . First, SOX2 dynamically searches and engages with the chromatin, priming target sites for OCT4 binding 44 . OCT4, in turn, stabilizes the binding of the OCT4-SOX2 complex on composite recognition sites 44 . A highly conserved residue of OCT4 (K156) is crucial for the OCT4-SOX2 interaction and for OCT4 protein stability within ESCs. Mutation of the OCT4-K156 residue results in the downregulation of stemness genes and the upregulation of mesendodermal genes that are involved in the epithelial-mesenchymal transition (EMT) 45 ( FIG. 2a) . Therefore, post-translational modification of OCT4-K156 may be a mechanism by which the OCT4-SOX2 complex is disassociated, which leads to specification of the mesendodermal lineage. Structural studies show that OCT4 and SOX2 can co-bind composite target DNAs in one of two complex configurations, depending on the positioning of their individual DNA-binding motifs 46 . In one configuration, OCT4 and SOX2 bind a no-gap canonical motif such that the octamer motif of OCT4 is immediately juxtaposed to the SOX2-binding motif. Examples of this configuration have been found by ChIP in the regulatory regions of Oct4, Utf1 (which encodes undifferentiated embryonic cell transcription factor 1) and Nanog 47 . In the alternative configuration, OCT4 and SOX2 bind to motifs that are separated by three base pairs, as is seen in the Fgf4 promoter (discussed below). Taking advantage of Sox2 mutations that interfere with specific OCT4-SOX2 heterodimer configurations, a recent study 48 showed that the OCT4-SOX2 configuration that dimerizes on the no-gap canonical motif has a more crucial role in somatic cell reprogramming and in ESC pluripotency than does any other configuration. This interesting finding suggests that a subset of target genes that are regulated by the core pluripotency transcription factors may help to define a minimum-required PGRN (FIG. 2b) .
Co-occupancy at transposable elements shapes the PGRN. It is worth mentioning that only a small subset of DNA sites bound by core transcription factors are bona fide regulatory elements of nearby genes 49 . It has been shown that changes in OCT4-SOX2-NANOG (OSN) occupancy do not correlate well with differential gene expression 49, 50 . Thus, the precise function of the majority of OSN-occupied sites remains unclear. One possibility is that by binding these sites, OSN may prime the local chromatin for subsequent action by transcription factors that are involved in differentiation, thereby promoting the exit from pluripotency. Interestingly, up to 25% of the OCT4-bound and NANOG-bound sites are within retrotransposons 51 . The divergence of transposable elements between mice and humans has resulted in a low level of sequence conservation in pluripotency transcription factor binding between the two species 51 . As such, transposable elements have contributed greatly to rewiring the PGRN in different mammalian species, yet the PGRN displays high levels of plasticity.
What roles do transposable elements have in the transcriptional regulation of pluripotency? Recent evidence suggests that they participate in the expression of species-specific pluripotency-associated genes via several mechanisms. First, as discussed above, they may recruit pluripotency transcription factors and act as enhancers of nearby genes 52, 53 . Second, they may be transcribed as non-coding RNAs that have regulatory functions (discussed below). Third, certain types of transposable elements are repressed in ESCs by Nature Reviews | Genetics On the one hand, these destabilizing effects may be buffered by the expression of other pluripotency-associated genes, the continued presence of self-renewal signals or other mechanisms that restore levels of the core TFs (for example, microRNAs (mi RNAs) that oppose differentiation) and return the PGRN to an optimal self-renewal state. On the other hand, in the presence of differentiation cues, the expression of lineage-specific TFs, epigenetic remodelling and pro-differentiation mi RNAs act together to dismantle the PGRN and to initiate the differentiation of the three germ layers.
co-repressors via epigenetic mechanisms that can spread and silence nearby genes. Hence, as a major constituent of the mammalian genome, transposable elements have an important role in shaping the PGRN. Future studies on these elements may help to reveal the inner workings of diverse pluripotent states.
Upstream signalling pathways and the PGRN Signalling pathways of conventional ESCs. The derivation and maintenance of ESCs require the activation or inhibition of multiple signalling pathways. Mouse ESCs were originally derived in the presence of irradiated fibroblasts and serum, which together supply LIF, WNT, bone morphogenetic protein 4 (BMP4) and other factors that support self-renewal 10, 11, 21 . Part of the reason that ESC cultures had been difficult to establish is that self-renewal is not an inherent feature of in vivo pluripotency. As alluded to above, the core pluri potency factors OCT4 and SOX2 activate Fgf4, which is an autocrine factor that feeds back through the FGF4-extracellular signal-regulated kinase (ERK) signalling pathway to promote differentiation 54, 55 . ESCs that lack FGF4 or ERK signalling have a severely limited propensity for neural and mesendoderm differentiation. ERK1 and ERK2 activation modulates chromatin occupancy of polycomb recessive complex 2 (PRC2) and RNA polymerase II (RNAPII) at developmental genes, which presumably promotes a state that is poised for the transcription of these genes 56 . Activation of the LIF and BMP signalling pathways can counteract the pro-differentiation effects of FGF4 and stabilize the pluripotent epiblast in a so-called conventional ESC state
. along chromosomes, SRY-box 2 (SOX2) first finds and binds to its target sites. This is followed by the recruitment of octamer-binding transcription factor 4 (OCT4). OCT4, in turn, stabilizes the binding of the OCT4-SOX2 complex to DNA, which ensures optimal expression of the self-renewal programme. The K156 residue of OCT4 is essential for stabilizing the salt bridge between D107 of SOX2 and K151 of OCT4. Post-translational modification (PTM) or mutation of K156 impairs the OCT4-SOX2 interaction and targets OCT4 for degradation. This results in the upregulation of mesendodermal genes that are involved in the epithelial-mesenchymal transition (EMT). b | The OCT4-SOX2 heterodimer can assume two different configurations. It was recently revealed that the OCT4-SOX2 configuration that binds to the no-gap canonical motif has a more important role than does the non-canonical OCT4-SOX2 configuration (which binds to motifs separated by a spacer) in the maintenance of pluripotency. The depicted gene networks (blue circles and adjoining black lines) represent a conceptual model of how target genes of the canonical OCT4-SOX2 heterodimer could form a network that has more relevance to pluripotency. The structural models of OCT4-SOX2 binding on DNA are adapted with permission from REF. 48 . Fgf4, fibroblast growth factor 4; Utf1, undifferentiated embryonic cell transcription factor 1.
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LIF signals through the transcription factor signal transducer and activator of transcription 3 (STAT3) to activate the self-renewal gene programme 57 . Among LIF-STAT3 targets are the pluripotency-associated genes Klf4 (which encodes kruppel like factor 4) and Tfcp2l1 (which encodes transcription factor CP2-like 1). Overexpression of Klf4 or Tfcp2l1 enables ESC selfrenewal without LIF [58] [59] [60] . TFCP2L1 stimulates a parallel circuit of self-renewal by upregulating NANOG, which itself supports LIF-independent self-renewal when overexpressed 60 . B cell lymphoma 3 protein (BCL-3) was recently shown to act downstream of LIF-STAT3 signalling to positively regulate pluripotencyassociated genes, possibly by associating with OCT4 and β-catenin 61 . BMP signals via the SMAD transcription factors to induce the inhibitor of differentiation genes and to thus prevent differentiation 62 . The effect of BMP signalling seems to be suppression of the neuroectoderm fate, whereas LIF represses non-neural differentiation. Therefore, conventional ESCs integrate competing signals from the FGF4-ERK, LIF-STAT3 and BMP-SMAD pathways to exist in a meta-stable state.
2i and ground-state ESCs. It is also possible to maintain ESCs without extrinsic signals (that is, without LIF and BMP). This is achieved by dual inhibition (2i) of the pro-differentiation MAPK/ERK kinase (MEK)-ERK signalling pathway and glycogen synthase kinase 3 (GSK3) with the small-molecule inhibitors PD0325901 and CHIR99021, respectively 63 . ESCs maintained in 2i media efficiently contribute to chimaera formation and germline transmission, display homogeneous expression of Nanog, display significantly reduced expression of differentiation-associated genes and resemble in vivo naive epiblast cells at the transcriptome level [63] [64] [65] . Because of these features, ESCs cultured in 2i media are said to be in the ground pluripotency state.
Blockade of FGF4-ERK signalling stabilizes the expression of Klf2, a gene that is essential for groundstate pluripotency 66 . Similarly, WNT-β-catenin signalling activates Klf2 expression 67 . Thus, dual inhibition of ERΚ and GSK3 promotes the pluripotency circuit that is controlled by KLF2. ERK also phosphorylates NANOG (another transcription factor that is crucial for the ground state), thereby reducing its transactivation activity and stability 68 . These data engendered a view that ERK signalling was dispensable for naive pluripotency and that FGF2-ERK signalling was instead required by primed epiSCs and human ESCs. This view has been challenged by recent genetic data. Surprisingly, Erk1-Erk2 double-knockout ESCs cannot be maintained. Acute loss of both ERKs quickly leads to telomere shortening, altered expression of pluripotencyassociated genes, reduced cell proliferation, G1 cell-cycle arrest and increased apoptosis 69 . These data also suggest that MEK inhibition in 2i ESCs may function through both ERK-dependent and ERK-independent mechanisms. Understanding the ERK-independent function of MEK will probably provide important insights into the ground-state PGRN.
Effectors of the LIF, BMP4 and WNT pathways (STAT3, SMAD1 and β-catenin-transcription factor 3 (TCF3), respectively) directly modulate the OSN core circuit by co-occupying enhancers that are bound by these core transcription factors 21, 36 . In the absence of nuclear β-catenin, TCF3 functions as a transcriptional repressor, and antagonizes the action of OCT4 and SOX2, which colocalize with TCF3 at pluripotency-associated genes 70 .
WNT stimulation relieves TCF3-medaited repression of its target genes in the PRGN, thereby reinforcing ESC self-renewal. For example, derepression of Esrrb (which encodes oestrogen-related receptor-β) is both necessary and sufficient for supporting self-renewal downstream of GSK3 inhibition 71 . By contrast, GSK3 inhibition is not necessary for ESC self-renewal, as LIF-STAT3 signalling can act alone to support naive pluripotency in the absence of Esrrb
71
. These data suggest that ground-state pluripotency is supported by parallel pathways. A systematic characterization of how upstream signals alter the global OSN-binding landscape has recently been provided 50 . During the 2i-induced transition from conventional ESCs to ground-state ESCs, all three core pluripotency transcription factors show rapid and widespread binding rearrangements. Differentially bound sites are enriched at distal enhancers, and tend to contain binding motifs for transcription factors that are associated with the canonical WNT and ERK signalling pathways (FIG. 3) . Specifically, sites with higher OSN binding under 2i conditions are enriched for binding motifs for lymphoid enhancer-binding factor 1 (LEF1), TCF7 and HOX proteins, which belong to the WNT pathway, whereas sites with decreased OSN binding are enriched for binding motifs for cofactors of the ERK pathway, such as early growth response protein 1 (EGR1), specificity protein 1 (SP1) and KLF7 (REF. 50 ). Although more work is needed to understand the functional relevance of these changes in OSN binding, this study provides mechanistic insights into the 2i state and the dynamics of the PGRN.
Box 1 | States of pluripotent stem cells
Mouse embryonic stem cells (ESCs) were first isolated from pre-implantation embryos that were explanted on feeder cells in the presence of serum 10, 11 . Leukaemia inhibitory factor (LIF) was later identified as a crucial factor for self-renewal, and it can eliminate the need for feeders. ESCs cultured in serum supplemented with LIF are referred to as conventional ESCs. Conventional ESCs display considerable heterogeneity and contain subpopulations that perform poorly in pluripotency assays. The conventional condition is not permissive for the derivation of ESCs from the non-obese diabetic (NOD) or FVB strains of mice. Replacing serum with inhibitors of MAPK/ERK kinase (MEK) and glycogen synthase kinase (GSK3; that is, dual inhibition (2i)) allows conventional ESCs to enter the so-called ground state, which is thought to closely resemble unrestricted in vivo naive pluripotency. ESCs cultured in the presence of 2i and LIF are characterized by uniform expression of key pluripotency transcription factors, reduced expression of differentiation-associated genes, global hypomethylation and the ability to contribute to chimaeras. The 2i-LIF condition also enables the derivation of ESCs from all strains of mice that have been tested to date. Developmentally more advanced or primed pluripotent stem cells (PSCs) require fibroblast growth factor 2 (FGF2) and activin A signalling to self-renew. Primed PSCs are characterized by lower expression of certain pluripotent factors (for example, NANOG, gut-enriched kruppel-like factor (KLF4) and REX1 (also known as zinc finger protein 42)) than in ESCs; bivalent epigenetic marks at lineage genes; female X-chromosome inactivation; and a poor contribution to blastocyst chimaeras 14, 15 .
Cofactors: the chromatin connection Transcriptional co-activators and co-repressors are protein complexes that do not bind DNA on their own but regulate the action of sequence-specific transcription factors via chromatin-mediated mechanisms. Because they serve as general regulators of transcription, a pluripotency-specific role of these factors was not suspected. Thus, it came as a surprise when several RNA interference (RNAi) screens revealed that ESCs are extremely sensitive to deficiencies in some of these cofactors (for example, Mediator and cohesin 72 , the 60 kDa Tat-interactive protein (TIP60)-p400 chromatinremodelling complex 73 , the RNA polymerase-associated factor 1 (PAF1) complex 74 , and the co-repressors CCR4-NOT transcription complex subunit 3 (CNOT3) and tripartite motif-containing protein 28 (TRIM28; also known as TIF1β and KAP1)) 75 . The requirement of Mediator and cohesin for the maintenance of pluripotency highlights the importance of 3D genome organization in the PGRN. Mediator and cohesin are large protein complexes that facilitate physical interaction between transcription factor-bound enhancers and promoters 76, 77 . The function of cohesin in forming chromatin loops in interphase nuclei is analogous to, but independent from, its role in sisterchromatid cohesion during mitosis. The transcription of pluripotency-associated genes depends on inter actions between distant regulatory elements. For instance, Nature Reviews | Genetics ESCs, core transcription factors bind naive-state-specific enhancers that are marked with methylation of histone H3 at K4 (H3K4me1) and acetylation of histone H3 at K27 (H3K27ac). OCT4 and SOX2 bind to these naive active enhancers together with other pluripotency factors that are expressed in the naive state, such as oestrogen-related receptor-β (ESRRB). In the primed pluripotency state, naive-state-specific enhancers become decommissioned, and this is correlated with downregulation of Esrrb and upregulation of Otx2 (which encodes orthodenticle homeobox 2). OTX2 retargets OCT4 to primed active enhancers, which gain enhancer-specific histone marks after the transition from the naive to the primed state.
the expression of Oct4 requires its upstream enhancer (when bound by OCT4, SOX2, KLF4, Mediator and cohesin) to come into contact with its promoter 78, 79 . KLF4 and cohesin are important organizers of these chromosomal interactions, as knockdown of either factor abolishes this Oct4 enhancer-promoter interaction, which leads to reduced Oct4 expression and the dissolution of pluripotency 78, 79 . A high-throughput survey of such 3D chromosomal interactions in ESCs and neural progenitor cells using carbon copy chromosome conformation capture (5C) technology (BOX 2) revealed that the vast majority of these interactions involve distinct combinations of Mediator, cohesin and CTCF 80 . Interestingly, these interactions show a hierarchical organization at different length scales. Cohesin and CTCF anchor long-range interactions (>1 Mb) that are invariant between cell types, whereas Mediator and cohesin (together with OSN) organize shortrange (<100 kb) enhancer-promoter interactions in an ESC-specific fashion 80 . The co-repressors CNOT3 and TRIM28 were identified in a genome-wide RNAi screen in mouse ESCs as factors that are essential for self-renewal. They cooccupy gene promoters with c-MYC and zinc finger X-chromosomal protein (ZFX), rather than OSN, and therefore form a distinct module of the PGRN that probably regulates proliferation, cell death and cancer 75 . TRIM28 is crucial for suppressing the transposition of endogenous retroviruses in ESCs and for silencing enhancers that are present within these retroelements (thereby preventing nearby genes from inappropriate activation) 81 . TRIM28 accomplishes these functions by interacting with SET domain bifurcated 1 (SETDB1) to induce heterochromatin formation 82 . TRIM28 has recently been shown to interact with polycomb repressive complex 1 (PRC1) and bind cooperatively with PRC1 at the promoters of differentiation-inducible genes to repress transcription 83 . By contrast, TRIM28 binds to pluripotency-associated genes without recruiting PRC1, thereby derepressing transcription 83 . Thus, the function of TRIM28 in ESCs is context dependent and may involve different epigenetic partners.
Several cofactors that are important in the PGRN have been identified by proteomic analyses of protein interaction networks involving pluripotency-associated genes. The orphan nuclear hormone receptor NR0B1 (also known as DAX1) was identified as a novel OCT4-interacting protein in a yeast two-hybrid screen 84 . Although NR0B1 is not essential for pluripotency, it is required to repress the transcription of Zscan4c (a two-cell-stage embryo-specific gene that encodes zinc finger-containing and SCAN domain-containing protein 4C) in mouse ESCs 85 . Overexpression of Zscan4c in the absence of NR0B1 disrupts normal selfrenewal by inducing G2 cell cycle arrest and cell death. Overexpression of NR0B1 supports LIF-independent self-renewal and does so without affecting STAT3 activation or ERK phosphorylation 86 . NR0B1 can inhibit extra-embryonic endoderm differentiation by binding to the promoter of Gata6 and inhibiting its transcription 86 . NR0B1 also inhibits trophectoderm differentiation either independently from or cooperatively with OCT4. It is proposed that NR0B1 and NANOG act in parallel to maintain an optimal pluripotent state 86 . It is worth noting that these investigations concerning the role of NR0B1 in the PGRN were carried out in conventional LIF-supplemented serum conditions. It will be interesting to determine whether NR0B1 carries out similar functions in the ground pluripotency state.
Mass spectrometry analysis of immunoprecipitated SOX2 protein complexes in ESCs revealed testisexpressed sequence 10 protein (TEX10) as a novel transcriptional cofactor in the PGRN 87 . Functionally, TEX10 is required for ESC maintenance, early embryo development, and efficient reprogramming of both mouse and human somatic cells 87 . The distribution of TEX10 binding across the genome strongly correlates with that of OSN and Mediator. In particular, TEX10 is enriched at ESC-specific superenhancers; these large clusters of enhancers are bound by OSN and Mediator, which positively regulate superenhancer activity. Mechanistically, TEX10 regulates superenhancer activity and the transcription of enhancer RNAs (eRNAs) by modulating histone acetylation and DNA demethylation through interactions with p300 and TET1 (REF. 87 ). The domain structure of the TEX10 protein is suggestive of interfaces for protein, DNA and RNA binding, which may enable TEX10 to regulate gene expression at multiple levels. It will be of great interest to further dissect the function of TEX10 in the PGRN.
CBFA2/RUNX1 translocation partner 2 (CBFA2T2) is another co-repressor that is important for the regulation of pluripotency. CBFA2T2 was identified via the proteomic analysis of proteins that interact with PR domain-containing 14 (PRDM14), which itself is a pluripotency factor that regulates DNA methylation and germ cell specification 88, 89 . Similarly to Prdm14-knockout ESCs, Cbfa2t2-knockout ESCs cannot be maintained under conventional serum conditions 89, 90 . Like PRDM14, CBFA2T2 represses lineage commitment genes in ESCs. Overexpression of CBFA2T2 also enhances iPSC reprogramming efficiency, as reported for PRDM14. Cbfa2t2-knockout mice show severe
Box 2 | 3D genome organization of embryonic stem cells
Similarly to the genomes of differentiated cells, those of embryonic stem cells (ESCs) are hierarchically organized. Traditional techniques, including fluorescence in situ hybridization (FISH) and immunostaining, have revealed that each chromosome occupies its own nuclear space known as a chromosome territory. The invention of chromosome conformation capture (3C) and 3C-derived technologies (for example, 5C and Hi-C) has greatly facilitated our understanding of the spatial organization of the genome at much finer scales 77 . This progress has produced the following concepts: A and B compartments, which are large active and inactive networks of interactions, respectively; topologically associating domains (TADs), which are self-contained regions of frequent local contacts; and short-range cis-regulatory interactions between enhancer and promoters 77 . TADs are relatively static structural units, whereas cis-regulatory interactions are highly dynamic and cell specific. In ESCs, high octamer-binding transcription factor 4 (OCT4)-SRY-box 2 (SOX2)-NANOG (OSN) occupancy is correlated with regions that are involved in long-range interactions, which suggests that OSN directly participates in the 3D organization of the genome 131, 132 . defects in primordial germ cell maturation and epigenetic reprogramming, which suggests that CBFA2T2 and PRDM14 belong to a regulatory network that is shared by the embryonic pluripotency and the latent pluripotency of the germline. CBFA2T2 and PRDM14 colocalize extensively throughout the genome and share many sites with OSN. The current mechanistic understanding is that CBFA2T2 oligomerizes to form a scaffold that helps to stabilize OCT4 and PRDM14 at their binding sites 90 .
RNA-based regulation of the PGRN It is now well established that many RNA-based regulatory mechanisms are crucial for the regulation of self-renewal and pluripotency. The diverse mechanisms of gene regulation by versatile RNA molecules not only expand and fine-tune the regulatory capacity of the PGRN, but also increase its proteomic diversity.
MicroRNAs. MicroRNAs (mi RNAs), which are a type of small non-coding RNA, are important for pluripotency 91 . This was first demonstrated by knocking out genes that are essential for miRNA biogenesis: namely, those that encode Dicer and DGCR8 91 . Data from these studies suggested that the main function of mi RNAs in ESCs is to promote cell-cycle progression 92 . ESC-specific miRNA clusters, such as miR-290 and miR-302, promote self-renewal and inhibit somatic differentiation 93 . miR-290 and miR-302 oppose the effects of the let-7 family of mi RNAs, which are broadly expressed in differentiated tissues and are required for maintaining the differentiated state 94 . A number of ESC-specific mi RNAs facilitate somatic cell reprogramming by targeting genes that are involved in multiple aspects of the reprogramming process 95 . Paradoxically, a recent study 96 showed that the miR-290 and miR-302 clusters promote the dismantlement of the naive pluripotency programme. These mi RNAs effectively silence naive pluripotency in Dgcr8-knockout ESCs, which cannot exit naive pluripotency or establish primed pluripotency. Several mechanistic targets (for example, the MEK pathway, Akt1 (which encodes RACα serine-threonine protein kinase) and Klf2) have been proposed to explain the seemingly contradictory and context-dependent functions of these mi RNAs 96 . However, the precise mechanism remains unclear.
Long non-coding RNAs. Long non-coding RNAs ( lncRNAs) have emerged as another important class of molecules that regulate pluripotency. Broadly defined as non-coding transcripts that are longer than 200 nucleotides, lncRNAs have diverse modes of action, including acting as molecular decoys, interfering with the transcription machinery, providing scaffolds for transcription factors and targeting epigenetic enzymes. Several conserved lncRNAs have been identified as direct targets of OCT4 and NANOG, and they directly modulate pluripotency-associated gene expression and differentiation 97 .
One such large intergenic non-coding RNA (lincRNA) regulator of reprogramming (lincRNA-ROR) modulates the reprogramming of human iPSCs 98 . A later study 99 demonstrated that lincRNA-ROR functions as a 'miRNA sponge' to trap other mi RNAs, thereby regulating the levels of core pluripotency transcription factors. LincRNA-ROR and mRNAs encoding core transcription factors share seed sequences with miR-145, which binds core transcription factor mRNAs and represses their translation 100 . In self-renewing ESCs, the levels of lincRNA-ROR exceed those of miR-145, which allows lincRNA-ROR to protect core transcription factors from miR-145-mediated suppression 99 . During differentiation, the situation reverses, allowing miR-145 to coordinate the exit from pluripotency 99 (FIG. 4) . This fascinating 'tug of war' between three RNA components (miRNA, lincRNA and mRNA) represents a new paradigm of post-transcriptional regulation in the PGRN.
Endogenous retroviruses are another abundant source of non-coding RNAs in human ESCs and iPSCs 101 107 , have been shown to regulate pluripotency. In addition, regulators of alternative splicing programmes, such as the muscleblind-like family of RNA-binding proteins and serine-arginine-rich splicing factor 2 (SRSF2), also have important regulatory roles in ESCs 107, 108 . For example, the pluripotency transcription factor OCT4, the splicing regulator SRSF2 and alternatively spliced MBD2 isoforms (MBD2a and MBD2c) participate in a positive feedback loop that is further regulated by mi RNAs, which nicely illustrates how different regulatory mechanisms work together to maintain pluripotency 107 (FIG. 4) . mRNA modification and ESC fate determination. . These data revealed considerable conservation of m 6 A-modified genes between the two species, which suggests that this RNA modification has functional importance in PSC biology 110 . Notably, mRNAs encoding core pluripotency transcription factors, including SOX2, NANOG and many other developmental regulators, are modified with m 6 A, whereas OCT4-encoding mRNA lacks this modification. The m 6 A-bearing transcripts show shorter halflife and an increased rate of mRNA decay compared with transcripts that lack m 6 A, which suggests that m 6 A is a mark associated with mRNA turnover 110, 111 . To understand the functional importance of m 6 A in PSCs, one study 111 knocked down Mettl3, a component of the m 6 A methylase complex, and reported that this led to reduced m 6 A levels in the majority of the modified genes and to compromised self-renewal. A later study 110 that relied on genetic knockout of Mettl3 confirmed the global reduction of m 6 A but challenged the previous conclusion that METTL3 is required for self-renewal. It showed that Mettl3-knockout mouse ESCs and METTL3-knockdown human ESCs have no defect in self-renewal or viability.
Instead, METTL3-depleted cells displayed persistent Nanog expression and impaired lineage commitment upon differentiation in vitro and in vivo 110 . Together, these studies show that m 6 A is an important regulator of the transcriptome flexibility of the PGRN and is required for the lineage differentiation of ESCs.
The wide gamut of pluripotent states Since ESCs were first successfully isolated from mouse embryos 35 years ago, pioneering research has greatly expanded the range of pluripotent states that can be either stabilized using defined culture parameters or artificially induced using genetic factors. From the original conventional naive ESCs, the spectrum of pluripotent states now extends from the 2i ground-state and transient totipotent-like cells (with both embryonic and extra-embryonic potentials) 112, 113 to primed EpiSCs and human ESCs (which are more developmentally advanced). In addition, there exist a range of intermediate states with distinct functional characteristics and practical advantages (as reviewed in REF. 114 ). For example, the spatial property of pluripotency was recently explored in the deri vation of a novel class of primed PSCs. These so-called region-selective epiSCs (rs-epiSCs) selectively integrate into the posterior proximal region of the post-implantation epiblast 18 . Analogous human region-selective PSCs can robustly contribute to interspecific chimaeras when injected into the posterior epiblast of post-implantation mouse embryos 18 . Unexpectedly, elevated expression of reprogramming factors in somatic cells can lead to an artificially stabilized NANOG-positive alternative pluripotent state, thus extending the concept of pluripotency outside of its normal developmental context 115 . Studying the relationships and potential interconversions between different pluripotency states can provide interesting insights into the regulation of pluripotency. In addition to differences in embryonic origin, morphology, signalling requirements and chimaera competency, which are discussed in the previous section, naive and primed PSCs have other molecular differences (as recently reviewed in REFS 114, 116) . For instance, global DNA hypomethylation is a hallmark of the naive epigenome. Interestingly, the reorganization of core transcription factor binding induced by 2i ground-state conditions in conventional ESCs happens rapidly with minimal changes to global DNA methylation 50 . Therefore, the genome-wide DNA demethylation that is observed in conventional ESCs following 2i culture 117 is likely to be the consequence rather than the cause of the reorganization of core transcription factor binding. Mechanistically, global loss of DNA methylation has been recently attributed to the simultaneous reduction of UHFR1 (an essential recruiting factor of DNA (cytosine-5)-methyltransferase 1 (DNMT1)) and its cognate histone mark dimethy lation of histone H3K9 (H3K9me2), which synergistically impair the DNA methylation maintenance machinery 118 . Similarly, the transition from naive ESCs to primed epiblast-like cells (epiLCs) is associated with genome-wide changes in NANOG binding, which correlate with epigenetic resetting of regulatory elements 119 . In this reconfigured epigenetic landscape, NANOG alone can induce a germ cell fate by activating the enhancers of key germline transcription factors 119 . Recent transcriptomic analyses coupled with genome-wide mapping of epigenetic markers and core transcription factor binding showed that the transition from naive to primed pluripotency involves global genomic retargeting of OSN and remodelling of the enhancer landscape 120, 121 . These dynamic changes do not result from changes in the expression of core transcription factors but are rather caused by redirection of core transcription factors by their binding partners (for example, orthodenticle homeobox 2 (OTX2)) in different cellular contexts (FIG. 3b) .
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Recently, the generation of naive-like human ESCs has garnered much attention from researchers in the field. Many methods have been devised to achieve this state, including the expression of naive transcription factors, and the application of specific combinations of cytokines and inhibitors (as reviewed in REF. 114 ). It was recently shown that a small-molecule inhibitor of MLL1 (also known as KMT2A), a histone H3K4 methyltransferase, could efficiently reprogramme mouse epiSCs to a state of naive pluripotency 122 . It will be interestingly to determine whether similar methods are effective in human ESCs. Despite interest and effort, ethical issues have prevented the development of definitive tests of naive pluripotency in human cells (for example, germline transmission and tetraploid complementation assays). Thus, the equivalence of these naive-like human ESCs to the gold-standard mouse naive ESCs has not been established.
Overall, research into alternative pluripotent states has greatly enriched our understanding of the PGRN. In turn, this knowledge has broadened the range of potential applications in regenerative medicine, including high-quality iPSCs, the generation of 3D organoids, efficient genome editing and precise modelling of diseases.
Perspectives
The PGRN is one of the most well-studied gene regulatory networks. The combined efforts of multiple laboratories have helped to elucidate the fundamental rules of transcription factor action, epigenetic modes of gene regulation and the 3D organization of the genome. From a developmental biology perspective, studying the PGRN provides unprecedented access to early development, especially early human development, for which an experimental model was previously lacking. Not only did ESCs 'pave the way' for the development of genetic engineering approaches that are based on homologous recombination, but they also currently serve as the metaphorical 'anvil' against which new genome editing technologies (for example, transcription activator-like effector nucleases (TALENs) and CRISPR-Cas9) are being 'hammered out' . Knowledge gained about the PGRN has guided progress toward safe and efficient iPSC technologies, which is an area of rapid development that holds great promise for regenerative medicine 126 . The development of human naive pluripotent cells that have the ability to contribute to interspecific chimaeras raises the captivating possibility of generating xenogenic organs 114 . It is clear that a foundational framework for understanding pluripotency has been established, but there are important discoveries that are yet to be made. We believe that an important task will be to further our understanding of the heterogeneity and plasticity of the PGRN, either during early embryonic development 127 or when induced by in vitro culture. To this end, single-cell analysis of the transcriptome and epigenome of PSCs has emerged as a powerful new method for studying the heterogeneity and dynamics of the PGRN [128] [129] [130] . To date, the study of the PGRN in different pluripotent states using multi-omics approaches has provided a series of snapshots of this important biological process. Similarly to photographs of a ballet, these still shots capture the inherent beauty of this biological system, but the fluidity and elegance are left to the imagination. Equipped with new technologies that enable us to precisely manipulate the genome and to quantitatively assess the transcriptome, epigenome, proteome and metabolome at the single-cell level, we are hopeful that the fascinating 'choreography' that governs the acquisition and dissolution of pluripotency in the embryo will be fully appreciated in the near future.
